No Data
INNOCARE (09969.HK) will release its Earnings Reports on March 27.
$INNOCARE (09969.HK) will publish its Earnings Reports on March 27, and investors should pay attention. Futubull reminder: 1. There are no strict regulations on the accounting year division for companies listed in Hong Kong and the U.S., which is entirely determined by the companies themselves, so each Earnings Reports period can be considered as the company's annual report deadline, rather than following the natural calendar year as the fiscal year. 2. Generally, the company will hold an earnings meeting on or around the above Earnings Reports release date, where company management will discuss and explain the latest quarterly Earnings Reports data and operational situation, and communicate with investors, Analysts, media, etc.
InnoCare Pharma Loss Narrows in 2024
Hong Kong stocks movement | INNOCARE (09969) surged over 5% after earnings; annual Shareholder's attributable loss narrowed by 30.2% year-on-year; the sales of Acalabrutinib grew rapidly.
INNOCARE (09969) has risen more than 5% after the earnings report, at the time of writing, it is up 5.16%, priced at 9.38 Hong Kong dollars, with a trading volume of 75.5825 million Hong Kong dollars.
Nuocheng Jianhua: Summary of the 2024 Annual Report of Nuocheng Jianhua Pharmaceutical Co., Ltd.
Nuocheng Jianhua: 2024 Annual Report of Nuocheng Jianhua Pharmaceutical Co., Ltd.
2024 Annual Report of Nuochengjianhua Pharmaceutical Co., Ltd.
